Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice

scientific article published on 28 March 2019

Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CMET.2019.03.004
P932PMC publication ID6583797
P698PubMed publication ID30930170

P50authorKe XuQ46184469
Cynthia T McMurrayQ88307093
P2093author name stringAmy Holt
Enrico Gratton
Jerry Vockley
Michael J Bennett
Do Yup Lee
Aris A Polyzos
Helen Budworth
Rupsa Datta
Meghan Hauser
Ken Frankel
Stephanie Mihalik
Kelly Trego
Pike Goldschmidt
P2860cites workNIH Image to ImageJ: 25 years of image analysisQ23319322
Cytoscape: a software environment for integrated models of biomolecular interaction networksQ24515682
Fluorescence lifetime imaging of free and protein-bound NADHQ24563134
Three-dimensional super-resolution imaging by stochastic optical reconstruction microscopyQ24642820
Assembly of endocytic machinery around individual influenza viruses during viral entryQ24669815
Genome-wide atlas of gene expression in the adult mouse brainQ26253934
Why does brain metabolism not favor burning of fatty acids to provide energy? Reflections on disadvantages of the use of free fatty acids as fuel for brainQ26825140
MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile dataQ27136473
The volatile compound BinBase mass spectral databaseQ27807490
Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM)Q27860490
The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's diseaseQ28072937
Mitochondrial Biology and Neurological DiseasesQ28076942
Increased susceptibility of striatal mitochondria to calcium-induced permeability transitionQ28183063
Adipose fatty acid oxidation is required for thermogenesis and potentiates oxidative stress-induced inflammationQ28255284
HdhQ111 Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid AccumulationQ28386493
Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypesQ28386769
Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila modelQ28389710
Neurological abnormalities in a knock-in mouse model of Huntington's diseaseQ28508179
Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's DiseaseQ28512442
Distinct pools of non-glycolytic substrates differentiate brain regions and prime region-specific responses of mitochondriaQ28534698
Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.Q30437121
Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truthQ30457642
Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's diseaseQ30979352
Energy defects in Huntington's disease: Why "in vivo" evidence matters.Q31131432
Differential loss of striatal projection neurons in Huntington diseaseQ33637273
Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model miceQ33781761
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS releaseQ33913079
Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescenceQ33937018
Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactionsQ34153434
Etomoxir mediates differential metabolic channeling of fatty acid and glycerol precursors into cardiolipin in H9c2 cellsQ34176172
MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarityQ34271370
Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's diseaseQ34309756
Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axonsQ34317568
Creatine supplementation lowers brain glutamate levels in Huntington's diseaseQ45239341
Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic miceQ45290567
Striatal hypometabolism in premanifest and manifest Huntington's disease patientsQ45295893
Neuropathological classification of Huntington's diseaseQ45297167
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.Q45299986
Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: indication of glial energy impairment in Huntington chorea, but not Parkinson diseaseQ45300611
Mechanisms underlying neurodegeneration in Huntington disease: applications to novel disease-modifying therapiesQ45304435
Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic miceQ45304684
The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1.Q45735127
Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cellsQ49145391
MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis.Q55518708
Threshold effect and tissue specificity. Implication for mitochondrial cytopathiesQ73176064
Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegenerationQ34458474
Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington diseaseQ35058593
Extending biochemical databases by metabolomic surveysQ35084955
Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington's disease.Q35167605
Fluorescence lifetime imaging of endogenous biomarker of oxidative stressQ35627204
Oxidative metabolism in YAC128 mouse model of Huntington's diseaseQ35924062
Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted ProfilingQ35977700
Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington's diseaseQ36159463
The phasor approach to fluorescence lifetime imaging analysisQ36303232
Phasor fluorescence lifetime microscopy of free and protein-bound NADH reveals neural stem cell differentiation potentialQ36373782
A Metabolic Study of Huntington's DiseaseQ36445216
Metabolic disruption identified in the Huntington's disease transgenic sheep modelQ36569413
Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model MiceQ36718633
Beyond the redox imbalance: Oxidative stress contributes to an impaired GLUT3 modulation in Huntington's diseaseQ36824396
Overexpression of glucose-6-phosphate dehydrogenase extends the life span of Drosophila melanogasterQ36973677
A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtinQ37153804
The phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington DiseaseQ37319246
Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease.Q37427280
Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.Q37456579
Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6/2 mice, a model of Huntington's diseaseQ37530288
Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Aggregation Causes Mitochondrial Dysfunction during Oxidative Stress-induced Cell Death.Q37735155
Energy deficit in Huntington disease: why it mattersQ37834195
Brain energy metabolism: focus on astrocyte-neuron metabolic cooperationQ37966074
Assembly factors of human mitochondrial respiratory chain complexes: physiology and pathophysiologyQ38021398
Cellular and molecular mechanisms of mitochondrial functionQ38061270
Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium HandlingQ38458943
The role of mitochondrial disturbances in Alzheimer, Parkinson and Huntington diseasesQ38532744
Astrocytes: a central element in neurological diseasesQ38670385
Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biologyQ38818625
The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell countingQ38836341
Respiration-Deficient Astrocytes Survive As Glycolytic Cells In Vivo.Q38896993
Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseasesQ38918493
Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.Q40721588
Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapyQ41356691
Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: spare respiratory capacity and stochastic mitochondrial failureQ41494079
Astrocytes and oligodendrocytes in grey and white matter regions of the brain metabolize fatty acidsQ41542336
Peroxisomal fatty acid beta-oxidation in HepG2 cellsQ41665569
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in miceQ44316963
P4510describes a project that usesImageJQ1659584
CytoscapeQ3699942
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectdouble-strand break repairQ14818014
Huntington's diseaseQ190564
reprogrammingQ402093
astrocyteQ502961
AstrocytesQ62556224
P304page(s)1258-1273.e11
P577publication date2019-03-28
P1433published inCell MetabolismQ1254684
P1476titleMetabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice
P478volume29

Reverse relations

cites work (P2860)
Q92577532Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis
Q97692894Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Q92861602Cellular Specificity and Inter-cellular Coordination in the Brain Bioenergetic System: Implications for Aging and Neurodegeneration
Q102379328Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot study
Q89982713Determining the bioenergetic capacity for fatty acid oxidation in the mammalian nervous system
Q96610193Explorative study of serum biomarkers of liver failure after liver resection
Q99549175Metabolic Constrains Rule Metastasis Progression
Q89963834Metabolic Regulation of Glial Phenotypes: Implications in Neuron-Glia Interactions and Neurological Disorders
Q90707611Mitochondria-Endoplasmic Reticulum Contacts in Reactive Astrocytes Promote Vascular Remodeling
Q99407805Neuronal metabolic rewiring promotes resilience to neurodegeneration caused by mitochondrial dysfunction
Q90753145Pleiotropic Mitochondria: The Influence of Mitochondria on Neuronal Development and Disease
Q101237342ROS networks: designs, aging, Parkinson's disease and precision therapies
Q92187419Selective Neuronal Death in Neurodegenerative Diseases: The Ongoing Mystery

Search more.